Literature DB >> 2526171

Marked elevation of serum dehydroepiandrosterone sulphate in Cushing's disease with macronodular adrenocortical hyperplasia.

J A Jackson1, J D Fachnie, R C Mellinger.   

Abstract

A 30-year-old man presented with longstanding hypercortisolism and biochemical studies typical of pituitary-dependent Cushing's disease. After unsuccessful transsphenoidal surgery, plasma ACTH transiently became undetectable and adrenal computed tomography (CT) was consistent with macronodular hyperplasia. Serum dehydroepiandrosterone sulphate (DHEA-S) exceeded 10,000 ng/ml (normal 2,000-3,350 ng/ml). Despite either transient adrenal autonomy or variable adrenocortical ACTH hyperresponsiveness, urinary cortisol normalized within eight months following pituitary irradiation alone. Serum DHEA-S fell progressively but remained mildly elevated (4,000 ng/ml). Follow-up CT showed minimal residual adrenal nodularity. Given these findings and a review of the literature, we propose that chronic cosecretion of non-ACTH proopiomelanocortinderived peptides may have stimulated both hypersecretion of DHEA-S and adrenocortical macronodularity in this patient.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2526171     DOI: 10.1007/BF03349984

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  CUSHING'S SYNDROME: NODULAR CORTICAL HYPERPLASIA OF ADRENAL GLANDS WITH CLINICAL AND PATHOLOGICAL FEATURES SUGGESTING ADRENOCORTICAL TUMOR.

Authors:  M A KIRSCHNER; R D POWELL; M B LIPSETT
Journal:  J Clin Endocrinol Metab       Date:  1964-10       Impact factor: 5.958

2.  Studies of the adrenal hyperfunction in 2 patients with atypical Cushing's syndrome.

Authors:  R C MELLINGER; R W SMITH
Journal:  J Clin Endocrinol Metab       Date:  1956-03       Impact factor: 5.958

Review 3.  Physiopathology of Cushing's disease.

Authors:  D T Krieger
Journal:  Endocr Rev       Date:  1983       Impact factor: 19.871

Review 4.  Biosynthesis and control of secretion of corticotropic, lipotropic and melanotropic peptides.

Authors:  F E Estivariz; G Gillies; P J Lowry
Journal:  Pharmacol Ther       Date:  1981       Impact factor: 12.310

Review 5.  Control of adrenal androgen secretion.

Authors:  L N Parker; W D Odell
Journal:  Endocr Rev       Date:  1980       Impact factor: 19.871

6.  The pathology of the adrenal gland in Cushing's syndrome.

Authors:  A M Neville; T Symington
Journal:  J Pathol Bacteriol       Date:  1967-01

7.  The development of bilateral adenomatous adrenal hyperplasia in a case of Cushing's syndrome of eighteen years' duration.

Authors:  M E Levin
Journal:  Am J Med       Date:  1966-02       Impact factor: 4.965

8.  Serum dehydroepiandrosterone sulfate in Cushing's syndrome.

Authors:  T Yamaji; M Ishibashi; H Sekihara; A Itabashi; T Yanaihara
Journal:  J Clin Endocrinol Metab       Date:  1984-12       Impact factor: 5.958

9.  Development of a radioimmunoassay for an amino-terminal peptide of pro-opiocortin containing the gamma-MSH region: measurement and characterization in human plasma.

Authors:  J Hope; S J Ratter; F E Estivariz; L McLoughlin; P J Lowry
Journal:  Clin Endocrinol (Oxf)       Date:  1981-09       Impact factor: 3.478

View more
  2 in total

1.  Cushing's syndrome due to ACTH-independent bilateral adrenocortical macronodular hyperplasia.

Authors:  M Terzolo; A Boccuzzi; A Ali; E Bollito; C De Risi; P Paccotti; A Angeli
Journal:  J Endocrinol Invest       Date:  1997-05       Impact factor: 4.256

2.  Coexistence of unilateral adrenal macronodule and Cushing's disease. Report of two cases.

Authors:  G Borretta; M Terzolo; F Cesario; I Meineri; A Pia; A Angeli
Journal:  J Endocrinol Invest       Date:  1996-02       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.